Loading clinical trials...
Loading clinical trials...
The primary objective for the study is to test the hypothesis that sertraline plus alprazolam XR will result in superior early stabilization of primary care PD patients versus sertraline/placebo over ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Indiana University School of Medicine
Collaborators
NCT06804525 · Major Depressive Episode (MDE), Major Depressive Disorder (MDD), and more
NCT06661460 · ANXIETY DISORDERS (or Anxiety and Phobic Neuroses), Specific Phobia, and more
NCT05467683 · Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder, and more
NCT04793828 · Panic Disorder With Agoraphobia, Panic Disorder Without Agoraphobia, and more
NCT05663489 · Obsessive-Compulsive Disorder, Social Anxiety Disorder, and more
University of South Florida, Department of Psychiatry and Behavioral Medicine
Tampa, Florida
University Hospital Outpatient Center, Psychiatry
Indianapolis, Indiana
University of Pennsylvania, Mood and Anxiety Disorders Section
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions